08.17.11
Unilife Corp. has made additions to its management team.
New senior appointments will support the launch of the Unifill ready-to-fill—prefilled—syringe to a number of pharmaceutical and biotechnology companies as well as accelerate the commercialization of other pipeline devices within the company's expanding portfolio of advanced drug delivery systems.
"The group of talented industry leaders that recently joined our team have strong backgrounds in the design, commercialization and sale of advanced drug delivery systems, further bolstering our existing capabilities and supporting our growth," said Alan Shortall, CEO of York, Pa.-based Unilife. "Having recognized our potential to rewrite the rulebook for the drug delivery industry, these veterans of established medical device companies have approached Unilife wanting to be part of its success and the future of the industry."
According to Ramin Mojdeh, chief operating officer of Unilife, the company now has reached a stage where it can attract "some of the most talented and respected professionals" in the drug delivery device industry.
"These industry leaders, who held senior leadership roles in companies such as BD and Medtronic, recognize the significant opportunity we provide pharmaceutical companies through our innovative, differentiated devices that can be customized to meet the specific needs of their biological pipelines," Mojdeh said. "Each of these new members of the Unilife team brings with them unique skills and expertise that will help us play a commanding role in redefining the industry from a place of ridged commodity offerings into one led by innovation and customer service."
Dr. Jack J. Kelley, III, was named vice president of Strategic Marketing. He brings more than 15 years of broad leadership experience across a number of businesses key to healthcare innovation and commercialization, including life science research, venture capital, investment banking, large cap medical device and pharmaceutical drug delivery. Dr. Kelley has held leadership positions in increasing levels of responsibility in multiple areas including research and development, business development, marketing and business leadership.
Dr. Kelley has worked at Medtronic, JP Morgan and Becton Dickinson. Most recently, he served as the worldwide director of Strategic Marketing and Business Development at BD Pharmaceutical Systems.
Prior to his industrial career, Dr. Kelley held a dual faculty appointment as a Research Assistant Professor at Dartmouth College in the Departments of Chemistry and Computer Science. Dr. Kelley has published multiple peer reviewed journal articles on the biophysical characterization of proteins and DNA in solution. He continues to leverage and build upon that scientific experience today by augmenting Unilife's bio-analytical services for pharmaceutical partners. He holds a Doctorate in Biophysical Chemistry from Dartmouth College, an MBA from the University of Michigan, and a Bachelor's degree in Chemistry from Marquette University.
Michael C. Ratigan was appointed vice president of Commercial Development of Unilife. He has more than 17 years of experience in the life-sciences industry as a business development professional managing product sales and marketing, customer acquisitions and business planning for two Fortune 500 companies and two European biotechnology companies. Most recently, Mr. Ratigan was the Director of Self Administration of Injectable Systems at BD, where he headed up several North American commercial development programs. Prior to joining BD, Ratigan was group product manager at Stryker Orthopaedics, where he was responsible for charting product development, and marketing and sales support of multiple product lines as well as the launch of two new products. He holds a Bachelor of Science degree in Marketing from Boston College.
Ian Hanson is the new director of Advanced Drug Delivery Systems. Hanson has a proven history of bringing drug delivery devices from concept stage through to commercial development, and is considered to be one of the world's foremost experts in subcutaneous infusion devices, according to Unilife's leadership. Hanson joins Unilife from Medtronic Diabetes, where he served as the senior engineering manager and the leader of Advanced Engineering and Systems Department. He holds a Master of Science in Mechanical Engineering degree from the University of California at Los Angeles, and a Bachelor of Science in Mechanical Engineering degree from the California Polytechnic State University.
New senior appointments will support the launch of the Unifill ready-to-fill—prefilled—syringe to a number of pharmaceutical and biotechnology companies as well as accelerate the commercialization of other pipeline devices within the company's expanding portfolio of advanced drug delivery systems.
"The group of talented industry leaders that recently joined our team have strong backgrounds in the design, commercialization and sale of advanced drug delivery systems, further bolstering our existing capabilities and supporting our growth," said Alan Shortall, CEO of York, Pa.-based Unilife. "Having recognized our potential to rewrite the rulebook for the drug delivery industry, these veterans of established medical device companies have approached Unilife wanting to be part of its success and the future of the industry."
According to Ramin Mojdeh, chief operating officer of Unilife, the company now has reached a stage where it can attract "some of the most talented and respected professionals" in the drug delivery device industry.
"These industry leaders, who held senior leadership roles in companies such as BD and Medtronic, recognize the significant opportunity we provide pharmaceutical companies through our innovative, differentiated devices that can be customized to meet the specific needs of their biological pipelines," Mojdeh said. "Each of these new members of the Unilife team brings with them unique skills and expertise that will help us play a commanding role in redefining the industry from a place of ridged commodity offerings into one led by innovation and customer service."
Dr. Jack J. Kelley, III, was named vice president of Strategic Marketing. He brings more than 15 years of broad leadership experience across a number of businesses key to healthcare innovation and commercialization, including life science research, venture capital, investment banking, large cap medical device and pharmaceutical drug delivery. Dr. Kelley has held leadership positions in increasing levels of responsibility in multiple areas including research and development, business development, marketing and business leadership.
Dr. Kelley has worked at Medtronic, JP Morgan and Becton Dickinson. Most recently, he served as the worldwide director of Strategic Marketing and Business Development at BD Pharmaceutical Systems.
Prior to his industrial career, Dr. Kelley held a dual faculty appointment as a Research Assistant Professor at Dartmouth College in the Departments of Chemistry and Computer Science. Dr. Kelley has published multiple peer reviewed journal articles on the biophysical characterization of proteins and DNA in solution. He continues to leverage and build upon that scientific experience today by augmenting Unilife's bio-analytical services for pharmaceutical partners. He holds a Doctorate in Biophysical Chemistry from Dartmouth College, an MBA from the University of Michigan, and a Bachelor's degree in Chemistry from Marquette University.
Michael C. Ratigan was appointed vice president of Commercial Development of Unilife. He has more than 17 years of experience in the life-sciences industry as a business development professional managing product sales and marketing, customer acquisitions and business planning for two Fortune 500 companies and two European biotechnology companies. Most recently, Mr. Ratigan was the Director of Self Administration of Injectable Systems at BD, where he headed up several North American commercial development programs. Prior to joining BD, Ratigan was group product manager at Stryker Orthopaedics, where he was responsible for charting product development, and marketing and sales support of multiple product lines as well as the launch of two new products. He holds a Bachelor of Science degree in Marketing from Boston College.
Ian Hanson is the new director of Advanced Drug Delivery Systems. Hanson has a proven history of bringing drug delivery devices from concept stage through to commercial development, and is considered to be one of the world's foremost experts in subcutaneous infusion devices, according to Unilife's leadership. Hanson joins Unilife from Medtronic Diabetes, where he served as the senior engineering manager and the leader of Advanced Engineering and Systems Department. He holds a Master of Science in Mechanical Engineering degree from the University of California at Los Angeles, and a Bachelor of Science in Mechanical Engineering degree from the California Polytechnic State University.